Navigation Links
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Date:1/14/2008

SAN DIEGO, Jan. 14 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, Ph.D., Neurocrine's Chief Operating Officer has been appointed President and Chief Executive Officer and a member of the Board of Directors of Neurocrine Biosciences. Gary Lyons will step down as President and Chief Executive Officer of Neurocrine and will continue to serve as a member of the Board of Directors.

"While this was a very difficult decision for me, I believe the time is right for a change in leadership of Neurocrine. With three Phase II products, $180 million in cash and an extremely talented and experienced management team and dedicated staff, Neurocrine is well positioned to emerge as one of the leading biotechnology companies under Kevin's leadership," said Gary Lyons.

"The Board is indebted to Gary for his dedication and service over the past 14 years and we are grateful that he will continue to share his knowledge and expertise as a Board member as he transitions his responsibilities to Kevin," said Joe Mollica, Chairman of the Board. "Dr. Gorman has been an integral part of Neurocrine since its founding and has played key roles in the company's success over the years. We look forward to working with Kevin in his new leadership capacity in setting the strategy and direction of the company going forward."

Dr. Gorman, 50, was appointed Chief Operating Officer in September 2006 after having served as Executive Vice President and Chief Business Officer of Neurocrine Biosciences. In this position Dr. Gorman was responsible for R&D, Business Development and Commercial operations. Before joining Neurocrine in 1993, Dr. Gorman was a principal of Avalon Medical Partners, L.P. where he wa
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Neurocrine Announces Work Force Restructuring
2. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
3. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
4. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
6. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
7. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
8. Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference
9. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... England , May 24, 2013 ... Mundipharma angefertigt – Bei der ... , 91 % der Teilnehmer einer groß ... nur 20 % laut GINA [*] -Definition [1] ... dass Menschen mit Asthma generell einer von vier Denkweisen ...
(Date:5/23/2013)... ELMSFORD, N.Y. , May 23, 2013  BioScrip, ... the Company will present at the Jefferies 2013 Global ... the Grand Hyatt New York. ... and Hai Tran , Chief Financial ... 11:30 a.m. Eastern Daylight Time.   About ...
(Date:5/23/2013)... Patheon Inc ., a leading provider ... pharmaceutical industry, will host a complimentary webinar on “Cleaning ... Tuesday, June 4, 2013 at 11 a.m. Eastern Standard ... comply with regulations for cleaning validation. Many companies ... and little evaluation of risk. Some companies have ...
(Date:5/23/2013)... Francisco, CA (PRWEB) May 23, 2013 ... who encourage all types of inventions. They focus on ... now noticing this community gravitate toward bringing their ideas ... the DIY Biology Movement, works on making projects using ... the DNA of plants to make them glow with ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2
... may inadequately stimulate a patient,s heart while undergoing a ... pulses mixing with the electronic pulses from the pacemaker. ... patient undergoing the MRI scan, according to research published ... Online . MRI is an imaging technique that ...
... the Nanyang Technological University (NTU) signed the Memorandum of ... Research (CNRS) and the Thales Group of Companies to ... are meeting again in Singapore to inaugurate the CNRS-International-NTU-Thales ... at the Research Techno Plaza, the CINTRA Laboratory aims ...
... FREMONT, Calif., Dec. 16 WaferGen Biosystems, Inc. (OTC ... analysis systems, today announced that it will be launching ... gene-expression profiling using its SmartChip(TM) Real-Time PCR System. ... microRNA panel of 885 microRNAs on a single SmartChip. ...
Cached Biology Technology:FDA researchers identify new MRI safety risk for patients with pacemakers 2New Singapore-French nanotech lab opens at NTU 2New Singapore-French nanotech lab opens at NTU 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4
(Date:5/23/2013)... cancer patients unnecessarily undergo surgery or harsh treatments ... slow-growing and aggressive forms of the disease. Researchers ... Medical Institutes are developing technology that allows patients ... relatively mild treatments or take drastic measures. , ... an associate professor of biomedical engineering at Case ...
(Date:5/23/2013)... in treating cerebral palsy with autologous cord blood. Following ... year old boy had been in a persistent vegetative ... months after treatment with the cord blood containing stem ... the child learned to speak simple sentences and to ... study, dispel the long-held doubts about the effectiveness of ...
(Date:5/23/2013)... and fastest growing open-access publishers, announces the launch ... and Biotechnology . , A broad scope ... and Biotechnology will provide a single open-access ... research to be disseminated and discussed. , ... provide an open-science and interactive web platform for ...
Breaking Biology News(10 mins):Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2
... Researchers at King,s College London have discovered how coral ... UV rays, leading scientists to believe these compounds could ... for humans. , The team has begun to uncover ... are produced and eventually hope to recreate them synthetically ...
... From medicine and food to energy and agriculture, ... to the challenges faced by societies in the 21st ... development of gluten-free wheat, could bring hope to those ... the world population nears seven billion people, biotechnology plays ...
... and the Child & Family Research Institute have shown that ... imprint on their sons, or daughters, genes an imprint ... are expressed later in life. The study, published online ... epigenetics the expression of genes as opposed to the ...
Cached Biology News:Tropical coral could be used to create novel sunscreens for human use, say scientists 2Tropical coral could be used to create novel sunscreens for human use, say scientists 3Parents' stress leaves lasting marks on children’s genes: UBC-CFRI research 2
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface....
Biology Products: